Objectives This study aimed to investigate the geographic distribution of carbapenem-
resistant Acinetobacter baumannii (CR-AB) isolates in the Asia-Pacific region. Methods We …

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-
lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB) …

To give an update on the molecular epidemiology and global distribution of carbapenemase
encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated …

The aim of this study was to investigate and compare the molecular epidemiology and
carbapenem resistance determinants in clinical Acinetobacter baumannii isolates collected …

Background Emerging carbapenem resistance among Acinetobacter baumannii clinical
isolates is a worldwide problem. Infections caused by A. baumannii are increasing and …

Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing
relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) …

Abstract Background Carbapenem-resistant Acinetobacter baumannii complex (CRABC)
has globally emerged as a serious public health challenge. This study aimed to describe …

Carbapenem-resistant Gram-negative bacteria, in particular the Acinetobacter baumannii-
calcoaceticus complex and Enterobacteriaceae, are escalating global public health threats …

Abstract Objectives Carbapenem-resistant Acinetobacter baumannii (CRAB) has become a
worldwide issue. This study aimed to characterise the epidemiology and genetic …

Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …